CVS Health stock is trading -8.7% below its average target price of $66.81 after marking a 4.0% during today's morning session. Analysts are giving the Large-Cap Pharmaceutical Retail company an average rating of buy and target prices ranging from $59.0 to $87.0 per share.
CVS Health's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 1.4%. The stock's short ratio is 1.93. The company's insiders own 0.11% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 81.9%. In conclusion, we believe there is mixed market sentiment regarding CVS Health.
Institutions Invested in CVS Health
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2024-03-31 | Vanguard Group Inc | 9% | 116,117,490 | $7,083,166,890 |
| 2024-03-31 | Blackrock Inc. | 7% | 87,101,436 | $5,313,187,596 |
| 2024-03-31 | State Street Corporation | 4% | 55,004,275 | $3,355,260,775 |
| 2024-03-31 | Capital World Investors | 3% | 43,776,874 | $2,670,389,314 |
| 2024-03-31 | Dodge & Cox Inc | 3% | 41,012,543 | $2,501,765,123 |
| 2024-03-31 | Capital International Investors | 3% | 37,917,923 | $2,312,993,303 |
| 2024-03-31 | FMR, LLC | 3% | 34,423,281 | $2,099,820,141 |
| 2024-03-31 | Morgan Stanley | 2% | 29,039,992 | $1,771,439,512 |
| 2024-03-31 | Geode Capital Management, LLC | 2% | 25,382,075 | $1,548,306,575 |
| 2024-03-31 | Bank of America Corporation | 1% | 16,159,874 | $985,752,314 |
